European Cancer Forum 2025: Innovation, Security and Sustainability
DUO-O trial: Durvalumab + Bevacizumab + Olaparib Improves PFS in Newly Diagnosed BRCA-Wild-Type Ovarian Cancer
10 Most Promising Cancer Drugs Not Yet Approved in 2025: Solid Tumors Edition by OncoDaily
CancerWorld Issue #110 (December) is Live
Samra Turajlić: Honoured to Receive the 2026 Pezcoller–EACR Translational Cancer Award
Tanja Obradovic: Eventful 2025 Year for Cancer Drugs-45 New or Accelerated Approvals by FDA
A New Invention: Nanoparticle-Based Salivary Biosensor for Early Detection of Oral Squamous Cell Carcinoma
Advancing Childhood Cancer Care at the 2025 St. Jude Global Alliance Convening
|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
1 event,
Virtual Event
The ESMO Guidelines: Real World Cases - Webinar Series: Gastroesophageal Cancer 2026 is a virtual event designed to help medical professionals apply the latest ESMO Clinical Practice Guidelines to the complex management of gastroesophageal cancers using real-world clinical cases. The webinar will be broadcast live virtually on February 25, 2026, at 18:30 CET. The discussion […] |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
1 event,
The ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing, Selecting, Treating 2026: Zurich is a two-day course for experienced oncologists and specialists, focusing on using precision medicine to manage patients with HR-positive, HER2-negative metastatic breast cancer. The event is scheduled to take place on March 4–5, 2026, in […] |
0 events,
|
0 events,
|
0 events,
|
|
|
0 events,
|
0 events,
|
1 event,
The ESMO - The Christie Preceptorship on Lung Cancer 2026: Manchester will be held from March 11-13, 2026, in Manchester, United Kingdom. The application deadline is January 21, 2026, at 23:59 CET, and the course is accredited for 16 ESMO-MORA category 1 points. The learning objectives cover the full spectrum of thoracic oncology, from screening […] |
2 events,
The ESMO Sarcoma and Rare Cancers Congress 2026 will take place from 12–14 March in Lugano, Switzerland, offering a premier platform for experts to share cutting-edge research and innovative treatment approaches in rare solid tumours. The congress will discuss the latest developments in diagnosis, treatment, molecular biology, and classification of sarcomas and other rare cancers. […] |
0 events,
|
||
|
1 event,
The ESMO Targeted Anticancer Therapies (TAT) Congress 2026 is a major scientific forum organized by the European Society for Medical Oncology (ESMO), focused on accelerating the delivery of life-changing anticancer therapies through early drug development. The congress will be held from March 16 to 18, 2026, at the Palais des Congrès in Paris, France. The […] |
1 event,
The ICHNO 2026, the 10th International Congress on Innovative Approaches in Head and Neck Oncology, will be held from 19–21 March 2026 in Seville, Spain, under the theme: “Driven by Biology, Centred on the Person.” This unique event—jointly organized by ESTRO, EHNS, and ESMO—will bring together the full spectrum of multidisciplinary expertise to explore the […] |
1 event,
|
1 event,
|
0 events,
|
||
|
0 events,
|
0 events,
|
1 event,
The European Lung Cancer Congress (ELCC 2026) will take place from 25–28 March 2026 in Copenhagen, Denmark, bringing together leading multidisciplinary societies dedicated to thoracic oncology. This congress serves as a key platform for advancing science, sharing education, and enhancing lung cancer care practices globally. With a comprehensive programme designed for medical oncologists, radiation oncologists, […] |
0 events,
|
|||
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|